可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Martin TJ , Smith IL ,Nolan RD, et al.Prostanoids in platelet2vascular interaction. Am J Cardiol, 1983; 52(2) : 22A.
[2]Kiernan FJ , Kluger J , Regnier JC, et al. Eporostend sodium (prostacyclin) infusion in acute myocardial infarction. Br Heart J , 1986; 56: 428.
[3]Serneri GGN , Masotti G, Poggesi L , et al. Reduced prostacyclin production in patients with different manifestation of ischemic heart disease. Am J Cardiol,1982; 49 (5) : 1146.
[4]Bayer B,Blass R, Forster W. Antiaggregation effect of prostacyclin (PGE1) in vivo. Br J P harmacol, 1979;66: 10.
[5]Popat KD, Pitt B. Hemodynamic effects of prostaglandin E1 in fusion in patients with acute
myocardial infarction and left ventricular failure. Am Heart J ,1982; 103 (4p t) : 485.
[6]柯发生, 蒋文平. 前列腺素E1治疗心绞痛的临床观察.临床心血管病杂志, 1995; 11 (2) : 88.